Order Article Reprints

Leung W-H, Shih J-W, Chen J-S, Mokgautsi N, Wei P-L, Huang Y-J. Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377. Biomedicines. 2025; 13(3):547. https://doi.org/10.3390/biomedicines13030547

Leung, Wai-Hung, Jing-Wen Shih, Jian-Syun Chen, Ntlotlang Mokgautsi, Po-Li Wei, and Yan-Jiun Huang. 2025. "Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377" Biomedicines 13, no. 3: 547. https://doi.org/10.3390/biomedicines13030547

Leung, W.-H., Shih, J.-W., Chen, J.-S., Mokgautsi, N., Wei, P.-L., & Huang, Y.-J. (2025). Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377. Biomedicines, 13(3), 547. https://doi.org/10.3390/biomedicines13030547